Regulus Therapeutics Inc
Change company Symbol lookup
Select an option...
RGLS Regulus Therapeutics Inc
KO Coca-Cola Co
BAC Bank of America Corp
HXL Hexcel Corp
RDHL Redhill Biopharma Ltd
WASH Washington Trust Bancorp Inc
ADC Agree Realty Corp
FB Facebook Inc
HSTM HealthStream Inc
AMZN Amazon.com Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return diseased cells to their healthy state. The Company's Regulus microMarkers division is focused on identifying microRNAs as biomarkers of human disease. It has a research collaboration with Biogen focused on the discovery of microRNAs as biomarkers for multiple sclerosis and has completed research for another pharmaceutical company to explore microRNAs as biomarkers for specific patient populations. The Company is developing RG-101, an N-Acetylgalactosamine (GalNAc)-conjugated anti-miR targeting miR-122; RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome, and RG-125, a GalNAc-conjugated anti-miR targeting microRNA-103/107.

Closing Price
$1.14
Day's Change
-0.04 (-3.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.22
Day's Low
1.13
Volume
(Below Average)
Volume:
43,932

10-day average volume:
51,140
43,932
  • Prev Close
    1.18
  • Today's Open
    1.20
  • Day's Range
    1.13-1.22
  • Avg Vol (10-day)
    51.1K
  • Last (time)
    4:00p ET 07/23/19
  • Last (size)
    1.0K
  • 52-Wk Range
    0.80 - 4.07
    LowHigh
  • (08/23/18 - 12/24/18)
    42.50%
  • 104.4%
  • Market Cap
    23.7M
  • Shares Outstanding
    20.8M
  • -4.06
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.9
  • 48.06
  • (% of float 06/28/19)
    4.53

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.